Fresh analysis indicates that patients who discontinue popular GLP-1 drugs like semaglutide or tirzepatide can put back on shed pounds far faster than those who halt traditional diet and exercise programs.
Research printed in a major health publication demonstrates that while obese individuals can lose about a fifth of their total mass while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month after stopping.
"Individuals using these medications need to be aware of the risk of fast weight regain when the therapy concludes," cautioned lead investigator Dr. Susan Jebb.
That rate of recovery implies a return to original weight within about 18 months.
Weighing Treatments
The analysis, which reviewed dozens of studies involving thousands of patients, contrasted the effects of GLP-1 agonists with older methods.
Scientists point out that individuals who shed pounds through dieting typically experience a more gradual creep back—around 0.1 kg a month—after stopping.
Understanding the Rapid Regain
Doctors believe the way of the jabs accounts for the amplified weight return.
The injections copy a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Sustained high doses of the hormone levels far above than the body's typical production may cause the system to generate a reduced amount of its endogenous hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement means appetite is unsuppressed, making overeating far more likely."
A Lifelong Disease?
Health authorities recommend the jabs for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Professionals argue that, considering the significant potential of weight regain, the treatment is often long-term.
This view is reinforced by pharmaceutical companies, who say that the results "underscore the long-term character of excess weight," akin to managing conditions like diabetes.
User Experiences
Individuals who have come off the jabs explain a intense resurgence of hunger.
"It felt as if something flipping and I was suddenly ravenous," said an individual.
This challenge is compounded if patients have not established sustainable dietary or behavioural modifications during treatment.
Significant Use
Recent estimates indicate that a significant number of adults in the UK have used these injections in the last 12 months, with interest remaining high.
- Adoption is greater among women compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many obtain the drugs through private prescriptions rather than the NHS.
In conclusion, clinicians caution that while these medications are powerful agents for weight loss, they are not a standalone fix and lasting health benefits hinges on integrated lifestyle support.
